Gender effect on metformin and sitagliptin [Regulatives / Guidelines]

posted by khageswara Rao – India, 2022-03-01 08:26 (729 d 11:46 ago) – Posting: # 22816
Views: 1,202

Dear All,

As per updated guidelines

If a drug product is intended for use in both sexes, the applicant should include similar proportions of males and females in the study or provide a justification supporting the use of a single-sex population.

for metformin and Sitagliptin we have enrolled only male subjects so please provide the justification on the same of gender effect. with references.

Your quick response will much helpful

Thanks in advance.

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,638 registered users;
17 visitors (0 registered, 17 guests [including 3 identified bots]).
Forum time: 20:12 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5